Detection of human papillomavirus type 16 DNA in formalin-fixed, paraffin-embedded tissue specimens of gastric carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 12, 2007, Pages 1090-1096

  Ma, Tian You ^a   Liu, Wen Kang ^b   Chu, Yong Lie ^a   Jiang, Xiang Yang ^c   An, Yun ^a   Zhang, Mei Ping ^a   Zheng, Jian Wu ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b Department of Immunology and Pathogenic Microbiology   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

E6; Gastric carcinoma; Human papillomavirus type 16; In situ PCR; Liquid PCR

Indexed keywords

EOSIN; FORMALDEHYDE; HEMATOXYLIN; PARAFFIN;

ADULT; ARTICLE; BACTERIUM DETECTION; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CELL NUCLEUS; CELL TYPE; CHINA; CLINICAL ARTICLE; CORRELATION ANALYSIS; DNA DETERMINATION; EPITHELIUM CELL; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RATE; LYMPH NODE METASTASIS; MALE; METHODOLOGY; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STAINING; STATISTICAL ANALYSIS; STOMACH; STOMACH CARCINOMA; STOMACH MUCOSA; TISSUE SECTION;

ADENOCARCINOMA; ADULT; AGED; DNA, VIRAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; STOMACH NEOPLASMS;

EID: 36248979261     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282eeb4dc     Document Type: Article

References (46)

1. Favre M. Structural polypeptides of rabbit, bovine and human papillomaviruses. J Virol 1975; 15:1239-1247.
2. Zur Hausen H. Papillomavirus in human cancers. Proc Assoc Am Physicians 1999; 111:581-587.
3. Bonnez W, Reichman RC. Papillomaviruses. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia, PA: Churchill Livingston, Inc.; 2000. pp. 1630-1640.
4. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87:796-802.
5. Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Gynecol Oncol 1997; 65:23-29.
6. White AE, Livanos EM, Tlsty TD. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 1994; 8:666-677.
7. Ma D, Xi L. Progression of epidemiology and etiology on cervical carcinoma. J Practical Obstet Gynecol 2001; 17:61-62.
8. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003; 16:1-17.
9. Herrero R. Chapter 7: Human papillomavirus and cancer of the upper aerodigestive tract. J Natl Cancer Inst Monogr 2003; 31:47-51.
10. Xu CL, Qian XL, Zhou XS, Zhao QZ, Li YC. Expression of HPV16-E6 and E7 oncoproteins in squamous cell carcinoma tissues of esophageal cancer and noncancer tissues. Ai Zheng 2004; 23:165-168.
11. Xu WG, Zhang LJ, Lu ZM, Li JY, Ke Y, Xu GW. Detection of human papillomavirus type 16 E6 mRNA in carcinomas of upper digestive tract. Zhonghua Yi Xue Za Zhi 2003; 83:1910-1914.
12. Zhou XB, Guo M, Quan LP, Zhang W, Lu ZM, Wang QH, et al. Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium. World J Gastroenterol 2003; 9:1170-1173.
13. Shen ZY, Hu SP, Lu LC, Tang CZ, Kuang ZS, Zhong SP, et al. Detection of human papillomavirus in esophageal carcinoma. J Med Virol 2002; 68:412-416.
14. Lu Z, Chen K, Guo M. Detection of HPV in human esophageal cancer in high-incidence area and its correlation with p53 expression. Zhonghua Zhong Liu Za Zhi 2001; 23:220-223.
15. Li T, Lu ZM, Chen KN, Guo M, Xing HP, Mei Q, et al. Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis 2001; 22:929-934.
16. Fidalgo PO, Cravo ML, Chaves PP, Leitao CN, Mira FC. High prevalence of human papillomavirus in squamous cell carcinoma and matched normal esophageal mucosa: assessment by polymerase chain reaction. Cancer 1995; 76:1522-1528.
17. Zhang J, Ding Y, Zhou Z, Li H, Zhou B. Expression of human papillomavirus 16 E7 DNA in patients with colorectal adenocarcinoma. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2005; 22:1024-1026, 1044.
18. Zhu Q, Cao J, Li S. Detection of human papillomavirus gene in biopsies from colon carcinoma by PCR. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 1999; 13:352-354.
19. Audeau A, Han HW, Johnston MJ, Whitehead MW, Frizelle FA. Does human papilloma virus have a role in squamous cell carcinoma of the colon and upper rectum? Eur J Surg Oncol 2002; 28:657-660.
20. Lee YM, Leu SY, Chiang H, Fung CP, Liu WT. Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect 2001; 34:87-91.
21. McGregor B, Byrne P, Kirgan D, Albright J, Manalo P, Hall M. Confirmation of the association of human papillomavirus with human colon cancer. Am J Surg 1993; 166:738-740; discussion 741-742.
22. Shah KV, Daniel RW, Simons JW, Vogelstein B. Investigation of colon cancers for human papillomavirus genomic sequences by polymerase chain reaction. J Surg Oncol 1992; 51:5-7.
23. Boguszakova L, Hirsch I, Brichacek B, Faltyn J, Fric P, Dvorakova H, et al. Absence of cytomegalovirus, Epstein-Barr virus, and papillomavirus DNA from adenoma and adenocarcinoma of the colon. Acta Virol 1988; 32:303-308.
24. Roder DM. The epidemiology of gastric cancer. Gastric Cancer 2002; 1 (Suppl 5):5-11.
25. Zhu LZ, Su XL, Chen KN, Yang RJ, Xing HP, Cui JG, et al. Detection rate of human papillomavirus-16 in esophageal squamous cell carcinoma from different Chinese populations. Ai Zheng 2005; 24:870-873.
26. Liu WK, Chu YL, Zhang F, Chen P, Cheng F, Wang H, et al. The relationship between HPV16 and expression of CD44v6, nm23H1 in esophageal squamous cell carcinoma. Arch Virol 2005; 150:991-1001.
27. Damin DC, Caetano MB, Rosito MA, Schwartsmann G, Damin AS, Frazzon AP, et al. Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol 2007; 33:569-574.
28. Saegusa M, Hashimura M, Takano Y, Ohbu M, Okayasu I. Absence of human papillomavirus genomic sequences detected by the polymerase chain reaction in esophageal and gastric carcinomas in Japan. Mol Pathol 1997; 50:101-104.
29. Goodman AD, Mock DJ, Powers JM, Baker JV, Blumberg BM. Human Herpes virus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 2003; 187:1365-1376.
30. Shin YJ, Cho SW, Hahm KB, Kim YS, Kim JH, Park KH, et al. Localization of hepatitis B virus DNA in hepatocellular carcinoma by polymerase chain reaction in situ hybridization. J Korean Med Sci 1998; 13:377-382.
31. Wang BL, Chen XP, Zhai SP, Chen DF. Clinical significance of mrp gene in primary hepatocellular carcinoma. HBPD Int 2003; 2:397-403.
32. Ito M, Tanaka S, Kamada T, Haruma K, Chayama K, et al. Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis. World J Gastroenterol 2006; 12:10-16.
33. Takada K. Epstein-Barr virus and gastric carcinoma. J Clin Pathol: Mol Pathol 2000; 53:255-261.
34. Lavergne D, de Villiers EM. Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 1999; 80:681-684.
35. Kawaguchi H, Ohno S, Araki K, Miyazaki M, Saeki H, Watanabe M, et al. p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res 2000; 60:2753-2755.
36. Peixoto GD, Hsin LS, Snijders P, Wilmotte R, Herrero R, Lenoir G, et al. Absence of association between HPV DNA, TP53 codon 72 polymorphism and risk of esophageal cancer in a high-risk area of China. Cancer Lett 2001; 162:231-235.
37. Sur M, Cooper K. The role of the human papillomavirus in esophageal cancer. Pathology 1998; 30:348-354.
38. Zhan JY, Li Y, Shen BF. IL-6 selectively activates STAT3 in U937 cells. J Cell Mol Immunol 2001; 17:16-19.
39. Gloss B, Yeo-Gloss M, Meisterenst M, Rogge L, Winnacker EL, Bernard HU. Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. J Virol 1989; 63:1142-1152.
40. Yasumoto S, Taniguchi A, Sohma K. Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region. J Virol 1991; 65:2000-2009.
41. Chong T, Apt D, Gloss B, Isa M, Bernard HU. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription. J Virol 1991; 65:5933-5943.
42. Kamangar F, Qiao YL, Schiller JT, Dawsey SM, Fears T, Sun X-D, et al. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer 2006; 119:579-584.
43. Heim K, Widschwendter A, Pirschner G, Wieland U, Awerkiew S, Christensen ND, et al. Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic maker in cervical cancer. Am J Obstet Gynecol 2002; 186:705-711.
44. Skiba D, Mehlhorn G, Fasching PA, Beckmann MW, Ackermann S. Prognostic significance of serum antibodies to HPV-16 L1 virus-like particles in patients with invasive cervical cancer. Anticancer Res 2006; 26:4921-4926.
45. Bard E, Riethmuller D, Meillet D, Pretet JL, Schaal JP, Mougin C, et al. High-risk papillomavirus infection is associated with altered antibody responses in genital tract: nonspecific responses in HPV infection. Viral Immunol 2004; 17:381-389.
46. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12:17-20.